hers semaglutide fda Novo Nordisk sues Hims & over copycat weight-loss drugs Hers Online GLP-1 Clinic Review

Semaglutide is best known as a weight-loss drug, but SELECT was not a weight-loss study

At maximum doses, semaglutide produces approximately 15-17% body weight reduction

Visible signs include cloudiness, particles, color changes, or unusual consistency

-20C, 1 month (sealed storage, away from moisture and light) Publications (10) Journal Impact Factor Most Recent J Med Chem Discovery and Preclinical Evaluation of TPM003: A Novel GLP-1/GIP/Glucagon Triple Hormone Receptor Agonist with Robust Efficacy in Obesity and NASH

Key Features Triple Action Formula: Targets three metabolic pathways for enhanced weight reduction